Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 4/20 | 0.38 |
| ▸ | TK2 | O00142 | 2/20 | 0.36 |
| ▸ | TLR4 | O00206 | 3/20 | 0.36 |
| ▸ | SELP | P16109 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12762842 | 1.00 | MAPK1 (0.48) | MAPK1SLC2A1LGALS8LGALS3LGALS4 | |
| SCHEMBL12762834 | 0.93 | MAPK1 (0.40) | MAPK1GBA1TLR4 | |
| SCHEMBL12762843 | 0.93 | MAPK1 (0.40) | MAPK1GBA1TLR4 | |
| SCHEMBL12762878 | 0.86 | MAPK1 (0.48) | MAPK1SLC2A1GBA1TLR4SELP | |
| SCHEMBL10042132 | 0.82 | TLR4 (0.43) | MAPK1GBA1TLR4 | |
| SCHEMBL12762837 | 0.82 | MAPK1 (0.38) | MAPK1SLC2A1LGALS8LGALS3LGALS4 | |
| SCHEMBL12762845 | 0.82 | MAPK1 (0.38) | MAPK1SLC2A1LGALS8LGALS3LGALS4 | |
| SCHEMBL12762861 | 0.78 | MAPK1 (0.40) | MAPK1GBA1TLR4 | |
| SCHEMBL12762835 | 0.77 | TSHR (0.35) | MAPK1TLR4 | |
| SCHEMBL12762844 | 0.77 | TSHR (0.35) | MAPK1TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7906633-B2 | Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-03-15 | — | — | US | disclosed |